
The Arena
Altis Labs raises $25M to make an AI scan read a trial endpoint
A cancer-trial startup wants its model's reading of a CT scan to be the number a drug is judged by — and Apple's Siri home hub is already in employees' hands. Altis Labs raised $25 million to make an AI reading of a CT scan the thing a cancer trial is measured against. The round, announced September 17 and co-led by OrbiMed and Qiming Venture Partners USA, funds a company whose product is not a drug and not a chatbot: IPRO, a model that reads routine CT scans taken during oncology trials and re










